Implementation of a penicillin allergy screening tool to optimize aztreonam use

American Journal of Health-System Pharmacy

Volumn 73, Issue 5, 2016, Pages 298-306

  Staicu, Mary L ^a   Brundige, Mary Lourdes ^a   Ramsey, Allison ^a   Brown, Jack ^b   Yamshchikov, Alexandra ^a   Peterson, Derick R ^c   Baran, Andrea ^c   Laguio Vila, Maryrose ^a  

^a ROCHESTER GENERAL HOSPITAL   (United States)

^b ST JOHN FISHER COLLEGE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFEPIME; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ADULT; AGED; ALLERGIC REACTION; ARTICLE; CLINICAL ASSESSMENT TOOL; DRUG COST; DRUG SAFETY; DRUG UTILIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PENICILLIN ALLERGY SCREENING TOOL; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; RASH; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT DURATION; URINARY TRACT INFECTION; DRUG HYPERSENSITIVITY; DRUG UTILIZATION REVIEW; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AZTREONAM; DRUG HYPERSENSITIVITY; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MALE; MIDDLE AGED; PENICILLINS; PROSPECTIVE STUDIES;

EID: 84964037817     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp150288     Document Type: Article

References (28)

1. Dellit TH, Owens RC, McGowan JE Jr et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44:159-77.
2. Macy E, Ngor EW. Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. J Allergy Clin Immunol Pract. 2013; 1:258-63.
3. Macy E, Burchette RJ. Oral antibiotic adverse reactions after penicillin skin testing: Multi-year follow-up. Allergy. 2002; 57:1151-8.
4. Sogn DD, Evans R 3rd, Shepard GM et al. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med. 1992; 152:1025-32.
5. Gadde J, Spence M, Wheeler B, Adkinson NF Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA. 1993; 270:2456-63.
6. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin "allergy" in hospitalized patients: A cohort study. J Allergy Clin Immunol. 2014; 133:790-6.
7. Lee CE, Zembower TR, Fotis MA et al. The incidence of antimicrobial allergies in hospitalized patients: Implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med. 2000; 160:2819-22.
8. Gisbert JP, Pérez-Aisa A, Castro-Fernández M et al. Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin. Dig Liver Dis. 2010; 42:287-90.
9. Unger NR, Gauthier TP, Cheung LW. Penicillin skin testing: Potential implications for antimicrobial stewardship. Pharmacotherapy. 2013; 33:856-67.
10. Martinez JA, Ruthazer R, Hansjosten K et al. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med. 2003; 163:1905-12.
11. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: An updated practice parameter. Ann Allergy Asthma Immunol. 2010; 105:259-73.
12. Romano A, Viola M, Guéant-Rodriguez RM et al. Imipenem in patients with immediate hypersensitivity to penicillins. N Engl J Med. 2006; 354:2835-7.
13. Romano A, Viola M, Guéant-Rodriguez RM et al. Tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins. Ann Intern Med. 2007; 146:266-9.
14. Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010; 50:133-64. [Erratum, Clin Infect Dis. 2010; 50:1695.]
15. Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011; 52:e103-20.
16. National Institute of Allergy and Infectious Diseaes. Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events. http://rsc.tech-res.com/Document/safetyandpharmacovigilance/Table-for-Grading-Severity-of-Adult-Pediatric-Adverse-Events.pdf (accessed 2015 Jan 10).
17. Food and Drug Administration. Maxipime (cefepime) package insert. www.accessdata.fda.gov/drugsatfda-docs/label/2012/050679s036lbl.pdf (accessed 2015 Jan 10).
18. Park M, Markus P, Matesic D, Li JT. Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol. 2006; 97:681-7.
19. Li JT, Markus PJ, Osmon DR et al. Reduction of vancomycin use in orthopedic patients with a history of antibiotic allergy. Mayo Clin Proc. 2000; 75:902-6.
20. Wall GC, Peters L, Leaders CB, Wille JA. Pharmacist-managed service providing penicillin allergy skin tests. Am J Health-Syst Pharm. 2004; 61:1271-5.
21. Jones EM, Kirkpatrick BL, Feeney R et al. Hospital-acquired Clostridium difficile diarrhoea. Lancet. 1997; 349:1176-7.
22. Stone SP, Beric V, Quick A et al. The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphylococcus aureus colonization in acute elderly medical patients. Age Ageing. 1998; 27:561-8.
23. Ludlam H, Brown N, Sule O et al. An antibiotic policy associated with reduced risk of Clostridium difficile-associated diarrhoea. Age Ageing. 1999; 28:578-80.
24. Fowler S, Webber A, Cooper S et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: A controlled interrupted time series. J Antimicrob Chemother. 2007; 59:990-5.
25. Muto CA, Pokrywka M, Shutt K et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005; 26:273-80.
26. Pépin J, Saheb N, Coulombe MA et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: A cohort study during an epidemic in Quebec. Clin Infect Dis. 2005; 41:1254-60.
27. Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005; 353:2442-9.
28. Pichichero ME. Cephalosporins can be prescribed safely for penicillin-allergic patients. J Fam Pract. 2006; 55:106-12.